These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29720069)

  • 1. How much does tuberculosis cost? An Australian healthcare perspective analysis.
    Chan E; Nolan A; Denholm J
    Commun Dis Intell Q Rep; 2017 Sep; 41(3):E191-E194. PubMed ID: 29720069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis screening in an aged care residential facility in a low-incidence setting.
    Moyo N; Trauer J; Trevan P; Baker AM; Musemburi J; McGrath K; Nolan A; McIntyre E; Hulls J; Denholm JT
    Commun Dis Intell Q Rep; 2017 Sep; 41(3):E209-E211. PubMed ID: 29720065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRCLE: a randomised controlled cost comparison of self-administered short-course isoniazid and rifapentine for cost-effective latent tuberculosis eradication.
    Denholm JT; McBryde ES; Eisen D; Street A; Matchett E; Chen C; Shultz TR; Biggs B; Leder K
    Intern Med J; 2017 Dec; 47(12):1433-1436. PubMed ID: 29224209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India.
    Rupani MP; Cattamanchi A; Shete PB; Vollmer WM; Basu S; Dave JD
    Infect Dis Poverty; 2020 Oct; 9(1):144. PubMed ID: 33076969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study.
    Patel AR; Campbell JR; Sadatsafavi M; Marra F; Johnston JC; Smillie K; Lester RT
    BMJ Open; 2017 Sep; 7(9):e015108. PubMed ID: 28918407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
    Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
    Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of contact tracing completion and outcomes in tuberculosis: a 21-year retrospective cohort study.
    Saunders MJ; Koh GC; Small AD; Dedicoat M
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):640-6. PubMed ID: 24903932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost for tuberculosis care in developed countries: which data for an economic evaluation?
    Trieste L; Turchetti G
    J Rheumatol Suppl; 2014 May; 91():83-5. PubMed ID: 24789005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting.
    Dale KD; Abayawardana MJ; McBryde ES; Trauer JM; Carvalho N
    Am J Epidemiol; 2022 Jan; 191(2):255-270. PubMed ID: 34017976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential cost-effectiveness of rifampin vs. isoniazid for latent tuberculosis: implications for future clinical trials.
    Esfahani K; Aspler A; Menzies D; Schwartzman K
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1340-6. PubMed ID: 22283892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
    del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shifting the balance between in-patient and out-patient care for tuberculosis results in economic savings.
    MacIntyre CR; Plant AJ; Hendrie D
    Int J Tuberc Lung Dis; 2001 Mar; 5(3):266-71. PubMed ID: 11326826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National position statement for the management of latent tuberculosis infection.
    Stock D;
    Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of LTBI treatment for TB contacts in British Columbia.
    Tan MC; Marra CA; Sadatsafavi M; Marra F; Morán-Mendoza O; Moadebi S; Elwood RK; FitzGerald JM
    Value Health; 2008; 11(5):842-52. PubMed ID: 18489519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance with postexposure screening and treatment of latent tuberculosis infection among healthcare workers in a tertiary care hospital in Saudi Arabia.
    Balkhy HH; Miller TL; Ali S; Nuzzo JB; Kentenyants K; El-Saed A; McNabb SJ
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):176-81. PubMed ID: 24442081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tuberculosis programs in Thailand: a cost analysis.
    Chunhaswasdikul B; Kamolratanakul P; Jittinandana A; Tangcharoensathien V; Kuptawintu S; Pantumabamrung P
    Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):195-9. PubMed ID: 1439970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The economic aspects of the system of organizing antitubercular measures in Tomsk Province].
    Polivakho VV; Sharaburova OE
    Probl Tuberk; 2000; (5):32-5. PubMed ID: 11077849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.